Angelnews India

India : The Board of Directors of MedPlus Health Services Limited, in its meeting on February 2, 2024, has just approved the unaudited standalone and consolidated financial results of the Company for the quarter ending December 31, 2023.

Unaudited Consolidated Financial Results for the Quarter and Nine month period ended December 31, 2023

All Numbers are in
Rs Millions
Quarter Ended
Quarter Ended
Quarter Ended
Total Income14,512.6314,189.5412,016.75
Total Expenses14,313.0114,025.1011,854.62
Profit/ (loss) before tax199.62164.44162.13
Net Profit after tax137.05145.44133.81
Total comprehensive income for the period149.57168.21131.80

MedPlus Health Services Limited Financial Results Highlights :

Revenue :

  • There was a ₹ 2,512 million increase compared to Q3FY23, representing a 21.1% year-over-year (YoY) growth.
  • Additionally, there was a ₹ 329 million increase compared to Q2FY24, reflecting a 2.3% quarter-over-quarter (QoQ) increase.
  • Furthermore, there was a 0.7% increase in private label sales compared to Q3FY23.

Store Additions :

  • 144 Store Net Additions
  • There were 164 gross additions.
  • 89 net additions beyond Tier-One.
  • The total number of stores stood at 4,233 as of December 31, 2023.
Pharmacy Operating EBITDA :
  • The Pharmacy division achieved a 3.6% Operating EBITDA margin, which increased by 40 basis points (bps) quarter-over-quarter (QoQ).
  • The Company’s Operating EBITDA amounted to ₹ 466 million.

Leave a Reply

Your email address will not be published. Required fields are marked *